CRISPR expands insight into the mechanisms of ALS and FTD

Sarah Pickles; Leonard Petrucelli

doi:10.1038/s41582-018-0005-z

CRISPR expands insight into the mechanisms of ALS and FTD

Sarah Pickles, Leonard Petrucelli

Neuroscience

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	321-323
Number of pages	3
Journal	Nature Reviews Neurology
Volume	14
Issue number	6
DOIs	https://doi.org/10.1038/s41582-018-0005-z
State	Published - Jun 1 2018

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1038/s41582-018-0005-z

Cite this

@article{2f50a06a4dad41339a98c7f7df53716d,

title = "CRISPR expands insight into the mechanisms of ALS and FTD",

author = "Sarah Pickles and Leonard Petrucelli",

note = "Funding Information: This work was supported by the Canadian Institute of Health Research (S.P.); National Institutes of Health/National Institute of Neurological Disorders and Stroke (R35NS097273 (L.P.); P01NS084974 (L.P.); P01NS099114 (L.P.); R01NS088689 (L.P.); R35NS097263 (L.P.); R21NS084528 (L.P.)); National Institute of Environmental Health Services (R01ES20395 (L.P.)); Department of Defense (ALSRP AL130125 (L.P.)); Mayo Clinic Foundation (L.P.); Amyotrophic Lateral Sclerosis Association (L.P.), Robert Packard Center for ALS Research at Johns Hopkins (L.P.), and Target ALS (L.P.). We would like to thank C. Cook, T. Gendron and Y.-J. Zhang for their thoughtful critiques.",

year = "2018",

month = jun,

day = "1",

doi = "10.1038/s41582-018-0005-z",

language = "English (US)",

volume = "14",

pages = "321--323",

journal = "Nature Clinical Practice Neurology",

issn = "1759-4758",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - CRISPR expands insight into the mechanisms of ALS and FTD

AU - Pickles, Sarah

AU - Petrucelli, Leonard

N1 - Funding Information: This work was supported by the Canadian Institute of Health Research (S.P.); National Institutes of Health/National Institute of Neurological Disorders and Stroke (R35NS097273 (L.P.); P01NS084974 (L.P.); P01NS099114 (L.P.); R01NS088689 (L.P.); R35NS097263 (L.P.); R21NS084528 (L.P.)); National Institute of Environmental Health Services (R01ES20395 (L.P.)); Department of Defense (ALSRP AL130125 (L.P.)); Mayo Clinic Foundation (L.P.); Amyotrophic Lateral Sclerosis Association (L.P.), Robert Packard Center for ALS Research at Johns Hopkins (L.P.), and Target ALS (L.P.). We would like to thank C. Cook, T. Gendron and Y.-J. Zhang for their thoughtful critiques.

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85046035324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046035324&partnerID=8YFLogxK

U2 - 10.1038/s41582-018-0005-z

DO - 10.1038/s41582-018-0005-z

M3 - Short survey

C2 - 29695800

AN - SCOPUS:85046035324

SN - 1759-4758

VL - 14

SP - 321

EP - 323

JO - Nature Clinical Practice Neurology

JF - Nature Clinical Practice Neurology

IS - 6

ER -

CRISPR expands insight into the mechanisms of ALS and FTD

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this